-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Multiple Myeloma Patients Carry a Substantial Number of Potentially Harmful Germline Variants

Program: Scientific Workshops @ ASH
Session: New Insights Into Germline Predisposition
Friday, December 4, 2020, 9:05 AM-9:52 AM

Marja Hakkarainen, MD

Helsinki University Hospital Comprehensive Cancer Center, The University of Helsinki, Helsinki, Finland

Disclosures: Hakkarainen: Academy of Finland: Research Funding; Sigrid Juselius Foundation: Research Funding; Helsinki University Hospital Comprehensive Cancer Research Funding: Research Funding; Cancer Foundation Finland: Research Funding; Väre Foundation for Pediatric Cancer Research: Research Funding; iCAN Digital Precision Cancer Medicine: Research Funding; Celgene: Research Funding; Oncopeptides: Research Funding.

See more of: New Insights Into Germline Predisposition
See more of: Scientific Workshops @ ASH
<< Previous Presentation | Next Presentation >>